2023 saw a number of different milestones that laid the foundation for a thriving space economy in the next decade.
The new contest aims to spur innovation into longer ‘healthspans’ with treatments that can actually reverse age-related degradation in body, mind and immune system.
Khosla Ventures-backed Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials.
Backed by US$120 million in venture funding, Stanford professor Christina Smolke’s company Antheia just completed its first scaled production of a key drug ingredient.
Spatial biology startup Resolve Biosciences is building up capital.
The new fund will be focused on startups in energy, manufacturing, agriculture, healthcare, satellites and more.